Oragenics, Inc.
OGEN
$0.86
$0.000.43%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.38% | 47.22% | 49.00% | 48.84% | -96.79% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.99% | -97.11% | -96.66% | -95.44% | 2,526.49% |
| Change in Net Operating Assets | 65.28% | 80.12% | 207.18% | -27.90% | -2.45% |
| Cash from Operations | -9.74% | -2.79% | 7.29% | -17.92% | 10.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -1,758.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -487.79% | -16.02% | -18.68% | -22.43% | -12.59% |
| Issuance of Common Stock | -60.46% | 79.31% | 177.80% | 685.02% | 625.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 175.44% | 165.75% | 329.06% | 2,006.66% | 1,509.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 414.94% | 112.20% | 119.04% | 67.03% | 67.96% |